Skip to content

Diabetic Ketoacidosis and Its Impact on the Brain

Diabetic Ketoacidosis and Its Impact on Neurocognition

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01753934
Enrollment
24
Registered
2012-12-20
Start date
2011-05-31
Completion date
2013-10-31
Last updated
2019-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

About the Study: This research study is being conducted to see if diabetic ketoacidosis has any impact on learning, behavior and development in children with Type 1 diabetes mellitus. If there is an impact, is it transient or persistent? Sixty to 80 children between the ages of 4 to 17 years with Type 1 diabetes mellitus will have neuropsychological testing and a non-sedated MRI scan of the head performed. The investigators will compare this to a control group of 30-40 children between the ages of 4 to 17 years without Type 1 diabetes mellitus. The children with Type 1 diabetes mellitus will not have any changes made to their current diabetes regimen. The children with Type 1 diabetes mellitus should continue to check blood glucose values as required by your doctor and bring their meter(s) for downloading to each visit. The children with Type 1 diabetes mellitus should also tell your doctor about the frequency of severe low and high blood glucose values.

Detailed description

Participant Schedule: 1. One visit for 3-4 hours at the Stanford Medical Center to complete neuropsychological testing and to become familiar with the MRI scanner. 2. Subjects who need to become more familiar with the MRI scanning process will view a video tape at home. 3. One visit for 1-2 hours at Stanford Medical Center to have the MRI scan of the head completed. 4. Subjects between 10 and 17 years of age will also be asked to complete two additional abbreviated neuropsychological tests at one week and one month from enrollment. 5. Subjects may have the complete neuropsychological testing and MRI scan repeated 15 months from time of enrollment.

Interventions

None listed

Sponsors

William E And Aenid R Weisgerber Foundation
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

To take part in the study, the participant must meet the following inclusion criteria: 1. Be between the ages of 4 to 17 years. 2. Either has been diagnosed with type 1 diabetes mellitus OR does not have type 1 diabetes mellitus

Exclusion criteria

If the interested participant has a history of head trauma with any loss of consciousness, prematurity (born less than 30 weeks of gestation), significant developmental delay (lack of single word speech or ability to walk independently by 18 months of age), neurologic disease independent of diabetes (eg seizure disorder or medical contraindication to MRI procedure (eg metal appliances such as braces).

Design outcomes

Primary

MeasureTime frameDescription
Memory score on ImPACT testing15 monthsThe computerized electronic testing generates a standardized test score at the complete of the test. The scores will be compared from enrollment, one week, one month and at 3 months. The change in score from enrollment to one week with be the main number used for analysis

Secondary

MeasureTime frameDescription
White matter volume on MRI using diffusion tensor imaging15 monthsValues will be calculated according to manuscript by Aye et al in Diabetes Care Sept 2012 electronically published ahead; available on line

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026